Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)
Clinical trial NCT01534455 · TERMINATED
Trial details
- NCT number
- NCT01534455
- Sponsor
- GBG Forschungs GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2015-03-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.